Applied DNA Sciences expands board by four
This article was originally published in Scrip
Applied DNA Sciences, a provider of DNA-based security, anti-counterfeiting technology and product authentication solutions, has elected four new members to its board: John Bitzer, president and CEO of ABARTA; Gerald Catenacci, founder and president of Neustrada Capital; Karol Gray, vice-president for finance & administration and CFO at the University at Stony Brook; and Charles Ryan, vice-president and chief intellectual property counsel at Forest Laboratories. These appointments increase the total number of board members to seven.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.